baber/WOPTO huggingface dataset:
Patent AU-2019284076-A1 (AU)
Title: Apparatus, systems and methods for row unit downforce control
Inventor: SAUDER DEREK A
IPC: A01C5/06
Filed: 2019-12-24
Abstract: APPARATUS, SYSTEMS AND METHODS FOR ROW UNIT DOWNFORCE CONTROL An agricultural implement having multiple row units, each row unit comprising at least one opening disc for opening a trench in soil and at least one gauge wheel for setting a depth of the trench, and having a system for applying downforce to the row units, the system comprising: a first actuator (500) disposed to apply force to a first row unit, said first actuator (500) including a first down chamber (515) and a first lift chamber (535), pressure in said first down chamber (515) tending to oppose pressure in said first lift chamber (535); a second actuator disposed to apply force to a second row unit, said second actuator including a second down chamber and a second lift chamber, pressure in said second down chamber tending to oppose pressure in said second lift chamber; a first downpressure control device (310) in fluid communication with said first down chamber (515) for controlling pressure in said first down chamber (515), said first downpressure control device (310) configured to maintain as a selected first downpressure any one of a continuous range of pressures in said first down chamber (515); a second downpressure control device in fluid communication with said second down chamber for controlling pressure in said second down chamber, said second downpressure control device configured to maintain as a selected second downpressure any one of a continuous range of pressures in said second down chamber, wherein said selected second downpressure is different from said selected first downpressure; a lift pressure control device (310) in fluid communication with both said first lift chamber (535)and said second lift chamber for controlling pressure in said first lift chamber (535) and said second lift chamber, said lift pressure control device (310) configured to maintain as a selected lift pressure any one of a continuous range of pressures in both said first lift chamber (535) and said second lift chamber, wherein said selected lift pressure is different from said selected first downpressure and said selected second downpressure; and processing circuitry in electrical communication with said first downpressure control device, said second downpressure control device, and said lift pressure control device, said processing circuitry configured to modify an operating state of said first downpressure control device, said second downpressure control device, and said lift pressure control device.
Patent AU-2019341667-A1 (AU)
Title: Method of manufacturing spacers for pipe-in-pipe systems and spacer for a pipe-in-pipe structure
Inventor: IRVIN DAVID JAMES
IPC: B29C70/58
Filed: 2019-09-18
Abstract: A method of manufacturing a spacer (26) for a pipe-in-pipe (30, 38) system comprises mixing aerogel particles (20) with a polymer (18) to form a mixture in which the particles (20) are dispersed in the polymer (18). The resulting mixture is moulded and the polymer is solidified to form the spacer (26) or a component of the spacer, in which the dispersed particles (20) are suspended in a matrix of the solidified polymer (18).
Patent AU-2019387628-A1 (AU)
Title: Lightweight asymmetric magnet arrays
Inventor: HAHAM HAY NOAM
IPC: G01R33/383
Filed: 2019-11-10
Abstract: A magnet array (100) includes multiple magnet rings (111-114, 121-124) and a frame. The multiple magnet rings are positioned along a longitudinal axis and are coaxial with the longitudinal axis. At least one of the magnet rings encircles a predefined inner volume (130). A minimal inner radius of the magnet rings positioned on one side of a center of the inner volume along the longitudinal axis is different from the minimal radius of the magnet rings positioned on the other side of the center of inner volume. The magnet rings are configured to jointly generate a magnetic field of at least a given level of uniformity inside the inner volume. The frame is configured to fixedly hold the multiple magnet rings in place.
Patent AU-2019422006-A1 (AU)
Title: Disambiguation of massive graph databases
Inventor: SRINIVAS SUDHIR
IPC: G06F16/00
Filed: 2019-07-29
Abstract: INTU/0367PC 
ABSTRACT 
Certain aspects provide techniques for disambiguating graph data. In one example, a 
method includes receiving entity data from a data source in a first format; converting the entity 
data in the first format to a second format, wherein the second format is a standardized input 
5 format for a disambiguation pipeline; determining a blocked data set from the entity data in the 
second format based on a blocking parameter, wherein: the blocked data set comprises data 
regarding a first plurality of entities, and the first plurality of entities is a subset of a second 
plurality of entities represented in the entity data from the data source; matching at least two 
entities in the first plurality of entities in the blocked data set; merging the at least two entities 
10 into a single entity; generating a unique ID for the single entity; and importing the single entity 
into a graph database.  
27
Patent AU-2019436089-A1 (AU)
Title: Low-frequency alternating-current electromagnetic elutriating machine
Inventor: LIU FENGLIANG
IPC: B03B7/00
Filed: 2019-04-25
Abstract: A low-frequency alternating-current electromagnetic elutriating machine, comprising: a washing separator (1), a concentrate cone (5), an overflow device (2), an ore feeding device (3), a water supply device, and a magnetic separation device. The magnetic separation device comprises ore gathering magnetic field coils (11) sleeved on the top of the outer periphery of the washing separator (1) and a plurality of traveling-wave magnetic field coils (9) located below the ore gathering magnetic field coils (11). Single-phase low-frequency alternating-current is fed into the ore gathering magnetic field coils (11), and three-phase low-frequency alternating-current is fed into the traveling-wave magnetic field coils (9). The traveling-wave magnetic field coils (9) are connected in "Y" or "△" shape. The frequency of the low-frequency alternating-current is lower than 50 Hz. Inductive magnetic rings (4) are provided at the positions corresponding to the ore gathering magnetic field coils (11) inside the washing separator (1). An inner overflow cylinder (21) has the same diameter as the washing separator (1). The ore outlet of the ore feeding device (3) is located at the middle between first and second traveling-wave magnetic field coils (9a, 9b) and the middle of between the inner wall of the washing separator (1) and the outer wall of an ore feeding pipe (31). A water supply device is provided in the concentrate cone (5) below the washing separator (1). The low-frequency alternating-current electromagnetic elutriating machine can achieve a high concentrate grade and good sorting effect, and has a wide range of application.
Patent AU-2019449147-A1 (AU)
Title: Illumination for photodynamic therapy
Inventor: LUEBBERT HERMANN
IPC: A61N5/06
Filed: 2019-06-05
Abstract: An illumination system (1) for photodynamic therapy is provided, the illumination system comprising an illumination source (2), which is configured to emit an electromagnetic radiation (3) to illuminate a target surface (4) during operation, and an electronic control unit (5), wherein the illumination source is configured such that the intensity of the electromagnetic radiation emitted by the illumination source can be varied, wherein the electronic control unit is operatively connected to the illumination source and configured to control operation of the illumination source according to an illumination protocol during an illumination session performed with the illumination system, and wherein the illumination protocol comprises instructions to operate the illumination source during the illumination session in a plurality of different modes, the modes comprising: a) a first mode, wherein, in the first mode, the electronic control unit controls operation of the illumination source such that the intensity of the electromagnetic radiation emitted by the illumination source is increased continuously or quasi-continuously from a base intensity B to a target intensity T within a first mode time interval, b) a second mode, wherein, in the second mode, the electronic control unit controls operation of the illumination source such that the intensity of the electromagnetic radiation emitted by the illumination source is constant or substantially constant for a second mode time interval, and c) a third mode, wherein, in the third mode, the electronic control unit controls operation of the illumination source such that the illumination source is operated such that darker phases and illumination phases alternate for a third mode time interval, wherein the intensity of the electromagnetic radiation emitted by the illumination source is lower in the darker phases than in the illumination phases, or wherein, in the darker phases the illumination source does not emit electromagnetic radiation whereas the illumination source emits electromagnetic radiation in the illumination phases. Furthermore, a computer program product and a kit for treating a disease are provided and a method for operating an illumination source and a method for treating a skin disease.
Patent AU-2019478718-A1 (AU)
Title: Membrane electrolysis cell and method of use
Inventor: ZHAO QIPENG
IPC: C25B13/08
Filed: 2019-12-20
Abstract: The present disclosure provides for an electrolytic cell having an electric circuit comprising an anode and a cathode separated by a hydrogel membrane, and an electrolytic system comprising a plurality of the electrolytic cells. The hydrogel membrane may comprise a hydrophilic polymer and acts as an electrolyte. A method of electrolysis, and a method of electrolysis of water, are also disclosed herein. The method may involve locating a hydrogel membrane comprising a hydrophilic polymer between an anode and a cathode of an electric circuit, absorbing liquid into the hydrogel membrane, and passing an electric current through the electric circuit. The liquid may be water. For the method of electrolysis of water, passing the electric current through the electric circuit may be such that the water in the hydrogel membrane is reduced to hydrogen at the cathode and oxygen forms at the anode.
Patent WO-2021022325-A1 (WO)
Inventor: ANDERSON JONATHAN PAUL
IPC: C12N15/82
Filed: 2020-08-03
Abstract: The present invention relates to new double stranded RNA (dsRNA) structures and their use in modulating flowering in plants. The present invention also relates to methods of modulating the time of plant flowering.
Patent AU-2020200803-A1 (AU)
Title: Systems and methods for interactive jewelry design
Inventor: KLEIN MOSHE
IPC: G06Q30/00
Filed: 2020-02-04
Abstract: Methods and systems are provided for designing a customized jewelry item via an electronic communications network. Some embodiments may include generating an interactive design tool. The interactive design tool may comprise an electronic template of a customized setting, which may comprise a plurality of sections. A user may select a section of a customized setting and a customizable feature of the selected section. A graphical representation of the customized setting with the customizable feature may be generated and displayed at a graphical user interface of an electronic display device. WO 2013/049735 PCT/US2012/058141 un; ELui -- --- --J La - ------
Patent AU-2020201896-A1 (AU)
Title: Novel peptides, combination of peptides and scaffolds for use in immunotherapeutic treatment of various cancers
Inventor: MAHR ANDREA
IPC: C07K14/47
Filed: 2020-03-16
Abstract: Abstract The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor associated T-cell peptide epitopes, alone or in combination with other tumor associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.
Patent AU-2020202382-A1 (AU)
Title: Methods and apparatus for transferring pressure during expression of human breast milk
Inventor: ALVAREZ JEFFREY B
IPC: A61M1/06
Filed: 2020-04-03
Abstract: A device for expression and collection of breast milk includes an actuatable assembly and a breast interface. The breast interface is sized to receive a breast and form a fluid tight seal against the breast. The breast interface includes an expandable membrane disposed within at least a portion of the breast interface. The expandable membrane reversibly deforms in response to actuation of the actuatable assembly, thereby applying vacuum pressure at the breast to express milk. The expandable membrane comprises a plurality of expandable pleats which extend radially outward from a central longitudinal axis of the breast interface. -22-
Patent AU-2020247722-A1 (AU)
Title: Machine-learning based fracture-hit detection using low-frequency DAS signal
Inventor: JIN GE
IPC: G06N20/00
Filed: 2020-03-11
Abstract: Various aspects described herein relate to a machine learning based detecting of fracture hits in offset monitoring wells when designing hydraulic fracturing processes for a particular well. In one example, a computer-implemented method includes receiving a set of features for a first well proximate to a second well, the second well undergoing a hydraulic fracturing process for extraction of natural resources from underground formations; inputting the set of features into a trained neural network; and providing, as output of the trained neural network, a probability of a fracture hit at a location associated with the set of features in the first well during a given completion stage of the hydraulic fracturing process in the second well.
Patent AU-2020256382-A1 (AU)
Title: Microarray for delivery of therapeutic agent and methods of use
Inventor: DING ZHONGLI
IPC: A61K9/00
Filed: 2020-10-15
Abstract: Microstructure arrays and methods for using and manufacturing the arrays are described.  
See Fig. 1A and 1B.
WO 2014/151654 PCT/US2014/026179 
1115 
..........  
..........  ..........  ..........  ..........  ..........  ..........  ..........  ..........  
..........  
....... ........  .... ........  
Xi 
: XXX.
FIG. 1A 
l\MON, \oMMEMEMEM' ......... ........  .... ............ ........ .......  '0 .... ...  ........ ......  INS ..... NN.  xa 
WN M 
IM 
......... .....  .......... ............  
\\W 
FIG. 1B
Patent AU-2020313880-A1 (AU)
Title: Body area network facilitated authentication or payment authorization
Inventor: OSBORN KEVIN
IPC: H04L65/00
Filed: 2020-07-09
Abstract: Disclosed are examples of a method, a wearable device and a system enabling authentication of a user of a payment account or completion of a purchase transaction via signals generated by the wearable device. A process may include a wearable device generating a modulated signal using an encryption algorithm. The modulated signal may contain authentication information related to the wearable device including a cryptographic authentication message. The modulated signal is output to a biological medium interface of the wearable device that is coupled to a biological medium of a wearer of the wearable device. The biological medium is operable to conduct the modulated signal. A receiving device processes including decrypting and demodulating the modulated signal received from the biological medium. Using the demodulated signal, the authentication information transmitted from the wearable device is obtained. Based on the obtained authentication information, a transaction may be authorized, or a user authenticated.
Patent AU-2020319903-A1 (AU)
Title: Avoidance of redundant signaling in multi-layer video bitstreams
Inventor: WANG YE-KUI
IPC: H04N19/52
Filed: 2020-10-06
Abstract: A method of decoding includes receiving a bitstream having a plurality of layers and a video parameter set (VPS), where the VPS includes a direct reference layer flag, where the direct reference layer flag equal to a first value specifies that a second layer is not a direct reference layer for a first layer, and where the direct reference layer flag equal to a second value specifies that the second layer is the direct reference layer for the first layer; deriving a reference layer flag by: initially setting the reference layer flag to the first value; and updating the reference layer flag to the second value when the direct reference layer flag has the second value; and decoding a picture from the first layer in accordance with the reference layer flag to obtain a decoded picture.
Patent AU-2020334258-A1 (AU)
Title: T cell production from RAG inactivated IPSCs
Inventor: BARKER LAURA JANE
IPC: A61K35/17
Filed: 2020-08-20
Abstract: This invention relates to the differentiation of recombination activating gene (RAG) inactivated progenitor cells into T cells through the expression of an exogenous T Cell Receptor (TCR). A population of T cells may be produced by a method that comprises (i) differentiating a population of RAG inactivated induced pluripotent stem cells (IPSCs) into mesoderm cells, (ii) differentiating the mesoderm cells (MCs) to produce a population of haemogenic endothelial cells (HECs), (iii) differentiating the HECs into a population of haematopoietic progenitor cells (HPCs), (iv) differentiating the population of HECs into progenitor T cells; and (v) maturing the progenitor T cells to produce a population of double positive CD4+ CD8+ T cells. The method may further comprise introducing a heterologous nucleic acid encoding an antigen receptor, such as a T Cell Receptor (TCR) or chimeric antigen receptor (CAR), into one of the RAG inactivated (a) IPSCs (b) MCs (c) HECs (d) HPCs or (e) the progenitor T cells. This may be useful for example in the production of T cells for immunotherapy.
Patent AU-2020336320-A1 (AU)
Title: Multi-directional load isolating mechanical fuse
Inventor: TABOR MATHEW
IPC: B66C15/00
Filed: 2020-08-25
Abstract: Aspects of the disclosure relate to a mechanical fuse (120). The mechanical fuse may include a top portion (200) having a first shear pin (270) configured to break when a predetermined side load is applied to the mechanical fuse. The mechanical fuse may also include a bottom portion (300) having a second shear pin (360), wherein the second shear pin is configured to break when a predetermined vertical load is applied to the mechanical fuse. Wherein the mechanical fuse may be arranged such that when the second shear pin is broken under the predetermined vertical load, the first shear pin also breaks before the bottom portion separates from the top portion, and when the first shear pin is broken under the predetermined side load, the second shear pin remains intact when the bottom portion separates from the top portion.
Patent AU-2020345678-A1 (AU)
Title: Systems and methods for docking stations removably attachable to display apparatuses
Inventor: DECAMP RONALD
IPC: G06G1/16
Filed: 2020-08-17
Abstract: Systems and methods for docking with an electronic host device may include a display apparatus with a display screen and a docking station receptacle and a docking station to removably attach to the display apparatus at the docking station receptacle. These may each include one or more direct connector(s) for creating interface(s) between them without the use of a separate cable when so attached. Via these interface(s), the docking station may communicate power to the display apparatus and data may be communicated between the docking station and the display apparatus. The docking station may include additional connector(s) for connecting to one or more additional display apparatuses. The docking station may include a host device connector and/or an integrated and/or removable wireless transceiver to communicate data to the docking station from a host device and/or other wireless network device(s) and/or power from the docking station to the host device.
Patent AU-2020360403-A1 (AU)
Title: Water soluble nonwoven webs for packaging harsh chemicals
Inventor: BRIDEWELL VICTORIA
IPC: C11D17/04
Filed: 2020-09-30
Abstract: Disclosed herein are unit dose articles comprising a packet with an outer wall which comprises a nonwoven web comprising sulfonate modified PVOH fiber forming materials and/or a blend of fiber forming materials comprising polyvinylpyrrolidone and a sulfonate modified PVOH, carboxyl modified PVOH, or both. Also disclosed herein, are said unit dose articles comprising a composition including a harsh chemical.
Patent AU-2020382666-A1 (AU)
Title: Zipper mattress attachment
Inventor: NEGUS NATALIE
IPC: A47C21/02
Filed: 2020-11-16
Abstract: A system can include a zipper that connects a mattress to a bed foundation. For example, the zipper can extend from a head end to a foot end of an adjustable foundation. For another example, a zipper can connect to a mattress along a seam of the mattress and/or to a foundation along a seam of a foundation. For another example, a first zipper can connect the mattress core to a second zipper and the second zipper can connect a foundation to the first zipper. For another example, first and second zippers can be substantially vertically aligned.
Patent AU-2020384237-A1 (AU)
Title: Detection of colorectal cancer and/or advanced adenomas
Inventor: BITENC MARKO
IPC: C12Q1/6886
Filed: 2020-09-21
Abstract: The present disclosure provides, among other things, methods for colorectal cancer and/or advanced adenoma detection (e.g., screening) and compositions related thereto. In various embodiments, the present disclosure provides methods for screening that include analysis of methylation status of one or more methylation biomarkers, and compositions related thereto. In various embodiments, the present disclosure provides methods for detection (e.g., screening) that include detecting (e.g., screening) methylation status of one or more methylation biomarkers in cfDNA, e.g., in ctDNA. In various embodiments, the present disclosure provides methods for screening that include detecting (e.g., screening) methylation status of one or more methylation biomarkers in cfDNA, e.g., in ctDNA, using MSRE-qPCR and/or using massively parallel sequencing (e.g., next-generation sequencing).
Patent AU-2020390236-A1 (AU)
Title: Use of BI853520 in cancer treatment
Inventor: WANG ZAIQI
IPC: A61P35/00
Filed: 2020-11-27
Abstract: The present invention relates to a method for treating a tumor with a KRAS mutation. In the method, a compound 2-fluoro-5-methoxy-4-[(4-(2-methyl-3-oxo-2,3-dihydro-1H-isoindole-4-oxyl)-5-trifluoromethyl-pyrimidine-2-yl)amino]-N-(1-methyl-piperidine-4-yl)benzamide or a pharmaceutically acceptable salt thereof is used, which can be administered alone or in combination with a KRAS inhibitor and/or an MEK inhibitor.
Patent AU-2020407069-A1 (AU)
Title: Medical products including silver antimicrobial, hydration medium and a stabilizing agent
Inventor: SILEIKA TADAS S
IPC: A61L29/16
Filed: 2020-12-16
Abstract: Medical products including hydrophilic coating containing silver antimicrobial, hydration medium and a stabilizing agent.